Indivior Pharmaceuticals, Inc.

INDV

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001625297

SEC filings (opens in a new tab)

In the last 90 days, Indivior Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 1 sale; 337 institutions reported holding it in 13F filings for Q2 2026, worth $4.98B in total; Oaktree Capital is the only superinvestor holding it.

Q1 2025 vs. Q4 2024

How the institutions holding Indivior Pharmaceuticals, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of INDV: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Of which not filed for Q1 2025	Q1 2025	Change
Holders	113	1	116	+4
Shares	77.8M	92.8K	91.3M	+13.6M (+17.6%)
Value	$974.8M	$1.19M	$866.0M	−$107.6M (−11.1%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Indivior Pharmaceuticals, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to INDV in Q1 2025
Institution	Shares	Value	% of portfolio
Point72 Asset Management, L.P.	1,886,231	$18.0M	0.05%
PFM Health Sciences, LP	1,159,833	$11.1M	0.85%
Mangrove Partners	712,798	$6.79M	0.77%
Acadian Asset Management LLC	665,042	$6.33M	0.02%
HRT Financial LP	254,685	$2.43M	0.02%
Squarepoint Ops LLC	201,577	$1.92M	0.00%
Jain Global LLC	146,507	$1.40M	0.03%
Tejara Capital Ltd	121,400	$1.16M	0.57%
LMR Partners LLP	88,783	$846.1K	0.02%
Quantessence Capital LLC	84,812	$808.3K	0.20%
Nuveen, LLC	84,724	$793.4K	0.00%
Point72 Asia (Singapore) Pte. Ltd.	66,271	$631.6K	0.17%
SEI Investments Co	58,672	$559.1K	0.00%
New York State Common Retirement Fund	30,960	$295.0K	0.00%
Catalyst Funds Management Pty Ltd	30,734	$292.9K	0.08%
State of Tennessee, Treasury Department	26,864	$256.0K	0.00%
Intrepid Family Office LLC	25,000	$238.3K	0.35%
Graham Capital Management, L.P.	24,480	$233.3K	0.01%
Y-Intercept (Hong Kong) Ltd	21,674	$206.6K	0.01%
Hudson Bay Capital Management LP	20,700	$197.3K	0.00%
CTC Alternative Strategies, Ltd.	10,100	$96.3K	0.12%
Schaper Benz & Wise Investment Counsel Inc	10,000	$95.3K	0.01%
Cannon Global Investment Management, LLC	10,000	$95.3K	0.26%
Optiver Holding B.V.	6,513	$62.1K	0.00%
Hexagon Capital Partners LLC	12	$114	0.00%

Sold out (21)

Institutions that held Indivior Pharmaceuticals, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of INDV in Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Liontrust Investment Partners LLP	1,326,647	$17.0M
Rokos Capital Management LLP	500,032	$6.21M
Foursixthree Capital LP	373,231	$4.64M
HighVista Strategies LLC	142,634	$1.83M
M&G Plc	110,039	$1.41M
Melqart Asset Management (UK) Ltd	104,790	$1.30M
Trexquant Investment LP	95,893	$1.19M
ADAR1 Capital Management, LLC	54,057	$671.9K
Aster Capital Management (DIFC) Ltd	52,662	$654.6K
Tudor Investment Corp Et Al	45,478	$565.3K
Man Group plc	45,365	$563.9K
Campbell & CO Investment Adviser LLC	25,391	$325.3K
Gotham Asset Management, LLC	26,121	$324.7K
Two Sigma Advisers, LP	21,700	$269.7K
JustInvest LLC	14,825	$184.3K
Stifel Financial Corp	12,675	$157.6K
Pale Fire Capital SE	10,001	$124.3K
Simplex Trading, LLC	4,703	$58.0K
Farther Finance Advisors, LLC	1,840	$22.9K
EverSource Wealth Advisors, LLC	252	$3.13K
FMR LLC	205	$2.55K

Not filed for Q1 2025 yet (1)

Institutions that held Indivior Pharmaceuticals, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding INDV in Q4 2024 that haven't filed for Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Nuveen Asset Management, LLC	92,759	$1.19M